• Severe, Atypical Skin Reactions With Amivantamab in NSCLC

    1 month ago - By Medscape

    Some of the cutaneous adverse events to amivantamab, which targets both EGFR and MET, can be severe and have atypical presentations, which led to dose reductions in five of six cases.
    MDedge News
    Read more ...